Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;19(22):2996-3003.
doi: 10.1080/15384101.2020.1838772. Epub 2020 Oct 28.

HOPS and p53: thick as thieves in life and death

Affiliations
Review

HOPS and p53: thick as thieves in life and death

Maria Agnese Della-Fazia et al. Cell Cycle. 2020 Nov.

Abstract

The oncosuppressor protein p53 plays a major role in transcriptionally controlling the expression of a number of genes, which in turn regulates many functions in response to DNA damage, oncogene triggering, oxidative, and additional cell stresses. A developing area of interest in p53 is the studies related to its cytoplasmic function(s). Many investigations revealed the significant role of p53 in the cytoplasm, acting in a transcriptional-independent manner in important processes related to cell homeostasis such as; apoptosis, autophagy, metabolism control, drug, and oxidative stress response. The studies on cytoplasmic p53 have shown intricate mechanisms by which posttranslational modifications allow p53 to perform its cytoplasmic functions. A number of ubiquitins, deubiquitins, and small ubiquitin-like proteins, have a pivotal role in controlling cytoplasmic stability and localization. Recently, HOPS/TMUB1 a novel small ubiquitin-like protein has been described as a vital molecule stabilizing p53 half-life, directing it to the mitochondria and favoring p53-mediated apoptosis. Furthermore, HOPS/TMUB1 competing with importin-α lessens p53 nuclear localization, thereby increasing cytoplasmic concentration. HOPS/TMUB1 as p53 modifiers could be attractive candidates to elucidate apoptosis or other important transcriptional-independent functions which are key in cancer research in order to develop new therapeutic approaches.

Keywords: Apoptosis; Hepatocyte Odd Protein Shuttling (HOPS); Liver regeneration; Mitochondrial Apoptosis; Nucleophosmin (NPM)/p19 Arf; Transmembrane and ubiquitin-like domain containing 1 (TMUB1); Tumor Suppressor Gene; Ubiquitin–Like Protein; p53.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author.

Figures

Figure 1.
Figure 1.
Schematic representation of the different activities of p53
Figure 2.
Figure 2.
HOPS crosstalk with other p53 modulators
Figure 3.
Figure 3.
Overview of HOPS impact on p53 activity in the cellHOPS is concerned in lengthening of p53 half-life inhibiting MDM2 E3 ligase activity. Upon DNA damage stresses, HOPS enhances p53 stability sustaining p53 cytoplasmic pool. Cytoplasmic p53 is than available for mitochondrial translocation and MOMP induction for apoptotic outcome. Moreover, HOPS can modulate importin α binding to p53, responsible for p53 nuclear import, thus reducing p53 transcriptional activation (upper panel). In the absence of HOPS apoptotic response to DNA damage inputs is reduced. In HOPS−/- models p53 half-life is shortened leading to cytoplasmic pool drop and in turn reduced mitochondrial apoptosis. Importin α binding to p53 is not hampered by HOPS competition and nuclear import is increased (bottom panel)

Similar articles

Cited by

References

    1. Li T, Kon N, Jiang L, et al. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell. 2012;149:1269–1283. - PMC - PubMed
    1. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ. 2003;10:431–442. - PubMed
    1. Muller PA, Vousden KH.. p53 mutations in cancer. Nat Cell Biol. 2013;15:2–8. - PubMed
    1. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137:413–431. - PubMed
    1. Comel A, Sorrentino G, Capaci V, et al. The cytoplasmic side of p53’s oncosuppressive activities. FEBS Lett. 2014;588:2600–2609. - PubMed

Publication types

MeSH terms